ID: ALA336292

Max Phase: Preclinical

Molecular Formula: C14H22Cl2N5O12P3S

Molecular Weight: 648.25

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): AR-C67085
Synonyms from Alternative Forms(1):

    Canonical SMILES:  CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O)[C@@H](O)[C@H]3O)c2n1

    Standard InChI:  InChI=1S/C14H22Cl2N5O12P3S/c1-2-3-37-13-19-10(17)7-11(20-13)21(5-18-7)12-9(23)8(22)6(32-12)4-31-36(29,30)33-35(27,28)14(15,16)34(24,25)26/h5-6,8-9,12,22-23H,2-4H2,1H3,(H,27,28)(H,29,30)(H2,17,19,20)(H2,24,25,26)/t6-,8-,9-,12-/m1/s1

    Standard InChI Key:  ZLIAJZQKKBOFJR-WOUKDFQISA-N

    Associated Targets(Human)

    Purinergic receptor P2Y11 134 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Purinergic receptor P2Y12 2369 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Bile salt export pump 2311 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Associated Targets(non-human)

    Rattus norvegicus 775804 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 648.25Molecular Weight (Monoisotopic): 646.9576AlogP: 1.12#Rotatable Bonds: 11
    Polar Surface Area: 269.90Molecular Species: ACIDHBA: 14HBD: 7
    #RO5 Violations: 3HBA (Lipinski): 17HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
    CX Acidic pKa: 0.79CX Basic pKa: 5.12CX LogP: -1.85CX LogD: -6.50
    Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.08Np Likeness Score: 0.44

    References

    1. Ingall AH, Dixon J, Bailey A, Coombs ME, Cox D, McInally JI, Hunt SF, Kindon ND, Teobald BJ, Willis PA, Humphries RG, Leff P, Clegg JA, Smith JA, Tomlinson W..  (1999)  Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy.,  42  (2): [PMID:9925726] [10.1021/jm981072s]
    2. Jacobson KA, Jarvis MF, Williams M..  (2002)  Purine and pyrimidine (P2) receptors as drug targets.,  45  (19): [PMID:12213051] [10.1021/jm020046y]
    3. Zetterberg F, Svensson P..  (2016)  State of affairs: Design and structure-activity relationships of reversible P2Y12 receptor antagonists.,  26  (12): [PMID:27133596] [10.1016/j.bmcl.2016.04.030]
    4. Warner DJ, Chen H, Cantin LD, Kenna JG, Stahl S, Walker CL, Noeske T..  (2012)  Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.,  40  (12): [PMID:22961681] [10.1124/dmd.112.047068]

    Source